Pancreatic cancer is one of the deadliest types of cancer, with fewer than 13% of people diagnosed with it surviving for more ...
A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...
A personalized mRNA vaccine for pancreatic cancer has shown early promise in a small phase 1 trial ... [+] of 16 people. A mRNA-based cancer vaccine has shown impressive results in a small trial ...
A false claim is circulating online that the European Medicines Agency (EMA) has acknowledged that mRNA vaccines have not ...
A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...
IFLScience on MSN7d
New mRNA Vaccine Against World's Biggest Infectious Killer Shows PromiseA new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...
Vietnam Investment Review on MSN2d
AIM Vaccine's mRNA Shingles Vaccine Submits Clinical Application to the U.S.As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in ...
There is new hope in the fight against pancreatic cancer after early trials showed that personalized mRNA vaccines can target ...
ABC News on MSN7d
Personal vaccine may reduce risk of pancreatic cancer returning after surgery, small study findsA personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
The Phase I data aligns with previous preclinical findings, showing over 95% protection in non-human primates, comparable to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback